Keywords
gingival enlargement
gingivectomy
overgrowth
Abstract
An increase in size of gingiva is a common clinical condition termed as gingival overgrowth. The definite aetiology is unknown. It is classified on the basis of aetiologic factors and pathologic changes. Both localised and generalised overgrowth are encountered commonly and patients are aesthetically, socially, psychologically and functionally disturbed until they revert back to the original contour. Localised gingival enlargement frequently is inflammatory and can also be associated with systemic diseases/condition (hormonal, nutritional, allergic, nonspecific conditioned) or neoplasic and sometimes false enlargement. DIGO is a well documented side effect with the use of anticonvulsant, immunosuppressant, and calcium channel blockers. Total 3% to 84.5% of subjects taking these drugs seem to have significant enlargement. Localised overgrowth are managed by proper diagnosis followed by controlling inflammation and other causative factors before surgical excision. DIGO is managed by drug replacement and surgical excision if required after nonsurgical treatment. Gingivoplasty of gingival margin is necessary to create self-cleansing and aesthetic architecture.
Keywords: DIGO; gingival enlargement; gingivectomy; overgrowth.
References
Agrawal AA. Gingival enlargements: Differential diagnosis and review of literature. World J Clin Cases. 2015 Sep 16;3(9):779-88.
Lee K. The fibrous epulis and related lesions. Granuloma pyogenicum,’Pregnancy tumour’, fibro-epithelial polyp and calcifying fibroblastic granuloma. A clinico-pathological study. Periodontics. 1968 Dec;6(6):277-92.
Dongari-Bagtzoglou A, American Academy of Periodontology. Academy Report. Informational paper: drug-associated gingival enlargement. J Periodontol. 2004;75(10):1424-31.
Newman MG, Takei H, Klokkevold PR, Carranza FA, editors. Carranza’s Clinical Periodontology – A South Asia Edition. 11th ed. New Delhi, India: Saunders, Elsevier; 2011.
Nishikawa S, Nagata T, Morisaki I, Oka T, Ishida H. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. J Periodontol. 1996 May;67(5):463-71.
Seymour RA, Heasman PA. Drugs and the periodontium. J Clin Periodontol. 1988 Jan;15(1):1-16.
Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine: Histopathologic findings. J Periodontol. 1987 Sep;58(9):639-42.
Yamasaki A, Rose GG, Pinero GJ, Mahan CJ. Ultrastructure of fibroblasts in cyclosporin A-induced gingival hyperplasia. J Oral Pathol. 1987 Mar;16(3):129-34.
Kataoka M, Kido J, Shinohara Y, Nagata T. Drug-induced gingival overgrowth--a review. Biol Pharm Bull. 2005 Oct;28(10):1817-21.
Thomason JM, Ellis JS, Jovanovski V, Corson M, Lynch E, Seymour RA. Analysis of changes in gingival contour from three-dimensional co-ordinate data in subjects with drug-induced gingival overgrowth. J Clin Periodontol. 2005 Oct;32(10):1069-75.
Liboon J, Funkhouser W, Terris DJ. A comparison of mucosal incisions made by scalpel, CO2 laser, electrocautery, and constant-voltage electrocautery. Otolaryngol Head Neck Surg. 1997 Mar;116(3):379-85.